{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:15:20Z","timestamp":1789823720709,"version":"4.0.1"},"reference-count":120,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,2,10]],"date-time":"2015-02-10T00:00:00Z","timestamp":1423526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2015,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Acne vulgaris<\/jats:italic>\n                    (acne) is a chronic inflammatory disease of the sebaceous gland, characterized by follicular hyperkeratinization, excessive colonization by\n                    <jats:italic>Propionibacterium acnes (P<\/jats:italic>\n                    .\u00a0\n                    <jats:italic>acnes<\/jats:italic>\n                    ) as well as immune reactions and inflammation. Despite an armamentarium of topical treatments available including benzoyl peroxide, retinoids and azelaic acid, topical antibiotics in monotherapies, especially erythromycin and clindamycin, are still used in Europe to treat acne. This intensive use led to antimicrobial\u2010resistant\n                    <jats:italic>P.\u00a0acnes<\/jats:italic>\n                    and staphylococci strains becoming one of the main health issues worldwide. This is an update on the current topical acne treatments available in Europe, their mechanism of action, their potential to induce antimicrobial resistance and their clinical efficacy and safety.\n                  <\/jats:p>","DOI":"10.1111\/jdv.12989","type":"journal-article","created":{"date-parts":[[2015,2,12]],"date-time":"2015-02-12T15:22:07Z","timestamp":1423754527000},"page":"1485-1492","source":"Crossref","is-referenced-by-count":52,"title":["Topical acne treatments in Europe and the issue of antimicrobial resistance"],"prefix":"10.1111","volume":"29","author":[{"given":"M.T.","family":"Leccia","sequence":"first","affiliation":[{"name":"Clinique de Dermatologie Allergologie et Photobiologie CHU A Michallon Grenoble France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Auffret","sequence":"additional","affiliation":[{"name":"H\u00f4pital Europ\u00e9en Georges Pompidou Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Poli","sequence":"additional","affiliation":[{"name":"H\u00f4pital Europ\u00e9en Georges Pompidou Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.\u2010P.","family":"Claudel","sequence":"additional","affiliation":[{"name":"Private Practice Tours France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Corvec","sequence":"additional","affiliation":[{"name":"Institut de Biologie des H\u00f4pitaux de Nantes Service de Bact\u00e9riologie\u2010Hygi\u00e8ne CHU de Nantes Nantes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Dreno","sequence":"additional","affiliation":[{"name":"Clinique de Dermatologie University Hospital Nantes France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,2,10]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"582","article-title":"Pathogenesis of acne vulgaris: what's new, what's interesting and what may be clinically relevant","volume":"10","author":"Bellew S","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_3_1","first-page":"615","article-title":"Pathogenesis of acne vulgaris: recent advances","volume":"8","author":"Bhambri S","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2537"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12224"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.08.048"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04374.x"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.01.019"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.618"},{"key":"e_1_2_6_10_1","first-page":"1331","article-title":"A call to limit antibiotic use in acne","volume":"12","author":"Thiboutot D","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2014.2309"},{"key":"e_1_2_6_12_1","first-page":"79","article-title":"Retinoid plus antimicrobial combination treatments for acne","volume":"4","author":"Feneran AN","year":"2011","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2836(03)00662-4"},{"key":"e_1_2_6_14_1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1128\/iai.35.1.71-78.1982","article-title":"Neutrophil chemotaxis by Propionibacterium acnes lipase and its inhibition","volume":"35","author":"Lee WL","year":"1982","journal-title":"Infect Immun"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1086\/314056"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2008.08.024"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-013-1409-7"},{"key":"e_1_2_6_18_1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/archderm.1981.01650090033020","article-title":"Topical erythromycin vs blank vehicle in a multiclinic acne study","volume":"117","author":"Jones EL","year":"1981","journal-title":"Arch Dermatol"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(80)80113-7"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(85)70074-6"},{"key":"e_1_2_6_21_1","first-page":"48","article-title":"Clinical and bacteriological evaluation of nadifloxacin 1% cream in patients with acne vulgaris: a double\u2010blind, phase III comparison study versus erythromycin 2% cream","volume":"16","author":"Plewig G","year":"2006","journal-title":"Eur J Dermatol"},{"key":"e_1_2_6_22_1","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4103\/0253-7613.89815","article-title":"Efficacy and safety of topical nadifloxacin and benzoyl peroxide versus clindamycin and benzoyl peroxide in acne vulgaris: a randomized controlled trial","volume":"43","author":"Choudhury S","year":"2011","journal-title":"Indian J Pharmacol"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2010.04601.x"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2010.04701.x"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2000.03701.x"},{"key":"e_1_2_6_26_1","first-page":"31","article-title":"Clindamycin 1.2% Tretinoin 0.025% Gel versus Clindamycin Gel treatment in acne patients: a focus on Fitzpatrick skin types","volume":"4","author":"Schmidt N","year":"2011","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.10.005"},{"key":"e_1_2_6_28_1","first-page":"15","article-title":"Cohort study on the treatment with dapsone 5% gel of mild to moderate inflammatory acne of the face in women","volume":"12","author":"Lynde CW","year":"2014","journal-title":"Skinmed"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656560903002097"},{"key":"e_1_2_6_30_1","first-page":"981","article-title":"Dapsone gel 5% for the treatment of acne vulgaris: safety and efficacy of long\u2010term (1\u00a0year) treatment","volume":"6","author":"Lucky AW","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_31_1","first-page":"593","article-title":"Antibiotic resistant acne","volume":"17","author":"Leyden JJ","year":"1976","journal-title":"Cutis"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1998.tb140250.x"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04690.x"},{"key":"e_1_2_6_34_1","first-page":"6","article-title":"Erythromycin\u2010induced resistance to clindamycin in Staphylococcus aureus","volume":"64","author":"Marr JK","year":"2005","journal-title":"Hawaii Med J"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.4103\/0022-3859.57393"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05067.x"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2009.04270.x"},{"key":"e_1_2_6_38_1","unstructured":"CDC.ANTIBIOTIC RESISTANCE THREATS in the United States 2013 Centers for Disease Control and Prevention2013. Available from:http:\/\/www.cdc.gov\/drugresistance\/threat-report-2013\/pdf\/ar-threats-2013-508.pdf. (last accessed: 16 October 2013)."},{"key":"e_1_2_6_39_1","unstructured":"Organization WH.The evolving threat of antimicrobial resistance \u2010 Options for action 2012. Available from:http:\/\/www.who.int\/patientsafety\/implementation\/amr\/publication\/en\/index.html(last accessed 16 October 2013)."},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.4103\/0022-3859.68637"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200012)43:12<2843::AID-ANR26>3.0.CO;2-2"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(01)00914-X"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2012.12.010"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3180616733"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2014.02.004"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2002.01371.x"},{"key":"e_1_2_6_47_1","first-page":"5","article-title":"Benzoyl peroxide: enhancing antibiotic efficacy in acne management","volume":"15","author":"Dutil M","year":"2010","journal-title":"Skin Therapy Lett"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656560903277228"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1986.tb04534.x"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1994.tb13101.x"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1992.tb00196.x"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(83)70005-8"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1586\/ecp.10.27"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb05014.x"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp033487"},{"key":"e_1_2_6_56_1","first-page":"417","article-title":"Antibiotic\u2010resistant Propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%","volume":"82","author":"Leyden JJ","year":"2008","journal-title":"Cutis"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70177-4"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(83)70211-2"},{"key":"e_1_2_6_59_1","first-page":"1033","article-title":"The efficacy, safety and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris; a randomized trial","volume":"12","author":"Babaeinejad SH","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_60_1","first-page":"197","article-title":"Delayed type hypersensitivity to benzoyl peroxide","volume":"3","author":"Shwereb C","year":"2004","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2006.00738.x"},{"issue":"4","key":"e_1_2_6_62_1","first-page":"7","article-title":"Adapalene in clinical practice","volume":"68","author":"Leyden J","year":"2001","journal-title":"Cutis"},{"issue":"2","key":"e_1_2_6_63_1","first-page":"8","article-title":"Topical retinoids in the treatment of acne vulgaris","volume":"64","author":"Bershad S","year":"1999","journal-title":"Cutis"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.5.2467"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.155"},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.1390s2003.x"},{"key":"e_1_2_6_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2007.00552.x"},{"key":"e_1_2_6_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02850266"},{"key":"e_1_2_6_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70443-8"},{"key":"e_1_2_6_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2004.03.009"},{"key":"e_1_2_6_71_1","first-page":"1104","article-title":"Adjunctive use of a facial moisturizer SPF 30 containing ceramide precursor improves tolerability of topical tretinoin 0.05%: a randomized, investigator\u2010blinded, split\u2010face study","volume":"11","author":"Schorr ES","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_72_1","doi-asserted-by":"publisher","DOI":"10.1159\/000067820"},{"key":"e_1_2_6_73_1","doi-asserted-by":"publisher","DOI":"10.2165\/0128071-200809060-00003"},{"key":"e_1_2_6_74_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.1390s2048.x"},{"issue":"2","key":"e_1_2_6_75_1","first-page":"14","article-title":"An update on the safety and efficacy of topical retinoids","volume":"75","author":"Phillips TJ","year":"2005","journal-title":"Cutis"},{"key":"e_1_2_6_76_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.1390s2017.x"},{"key":"e_1_2_6_77_1","first-page":"238","article-title":"Cumulative irritation potential of adapalene 0.1% cream and gel compared with tretinoin microsphere 0.04% and 0.1%","volume":"75","author":"Dosik JS","year":"2005","journal-title":"Cutis"},{"key":"e_1_2_6_78_1","doi-asserted-by":"publisher","DOI":"10.1067\/S0190-9622(03)01151-4"},{"issue":"4","key":"e_1_2_6_79_1","first-page":"25","article-title":"Polarized light photography and videomicroscopy greatly enhance the capability of estimating the therapeuic response to a topical retinoid (adapalene) in acne vulgaris","volume":"68","author":"Rizova E","year":"2001","journal-title":"Cutis"},{"key":"e_1_2_6_80_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.7.4919"},{"key":"e_1_2_6_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0095-4543(05)70196-2"},{"key":"e_1_2_6_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1993.tb03165.x"},{"key":"e_1_2_6_83_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1986.tb05764.x"},{"key":"e_1_2_6_84_1","first-page":"14","article-title":"Pharmacology and toxicology of azelaic acid","volume":"143","author":"Topert M","year":"1989","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"e_1_2_6_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(87)90023-1"},{"key":"e_1_2_6_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1988.tb03474.x"},{"key":"e_1_2_6_87_1","first-page":"8","article-title":"Azelaic acid\u2013biochemistry and metabolism","volume":"143","author":"Passi S","year":"1989","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"e_1_2_6_88_1","first-page":"75","article-title":"Azelaic acid: mode of action at cellular and subcellular levels","volume":"143","author":"Galhaup I","year":"1989","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"e_1_2_6_89_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0353.2004.04731.x"},{"key":"e_1_2_6_90_1","first-page":"13","article-title":"Versatility of azelaic acid 15% gel in treatment of inflammatory acne vulgaris","volume":"7","author":"Thiboutot D","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_91_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1986.tb02856.x"},{"key":"e_1_2_6_92_1","first-page":"359","article-title":"Antibiotic resistance of Propionibacterium acnes in acne vulgaris","volume":"15","author":"Swanson JK","year":"2003","journal-title":"Dermatol Nurs"},{"key":"e_1_2_6_93_1","doi-asserted-by":"publisher","DOI":"10.1159\/000017844"},{"key":"e_1_2_6_94_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.110748"},{"key":"e_1_2_6_95_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200203050-00007"},{"key":"e_1_2_6_96_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200809030-00010"},{"key":"e_1_2_6_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.06.040"},{"key":"e_1_2_6_98_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01884.x"},{"key":"e_1_2_6_99_1","first-page":"616","article-title":"Study results of benzoyl peroxide 5%\/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris","volume":"6","author":"Del Rosso JQ","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_100_1","doi-asserted-by":"publisher","DOI":"10.1177\/120347540100500109"},{"key":"e_1_2_6_101_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1992.tb00104.x"},{"key":"e_1_2_6_102_1","doi-asserted-by":"publisher","DOI":"10.1097\/WOX.0b013e31823dc02c"},{"key":"e_1_2_6_103_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1994.tb08519.x"},{"key":"e_1_2_6_104_1","first-page":"152","article-title":"Effect of zinc gluconate on Propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study","volume":"15","author":"Dreno B","year":"2005","journal-title":"Eur J Dermatol"},{"key":"e_1_2_6_105_1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2340\/0001555572250252","article-title":"Zinc salts effects on granulocyte zinc concentration and chemotaxis in acne patients","volume":"72","author":"Dreno B","year":"1992","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_6_106_1","first-page":"492","article-title":"Zinc salts inhibit in vitro Toll\u2010like receptor 2 surface expression by keratinocytes","volume":"17","author":"Jarrousse V","year":"2007","journal-title":"Eur J Dermatol"},{"key":"e_1_2_6_107_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04502.x"},{"key":"e_1_2_6_108_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03934.x"},{"key":"e_1_2_6_109_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12606985"},{"key":"e_1_2_6_110_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1994.tb02929.x"},{"key":"e_1_2_6_111_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546630500281957"},{"key":"e_1_2_6_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70069-T"},{"key":"e_1_2_6_113_1","first-page":"447","article-title":"Efficacy and tolerability of combined topical treatment of acne vulgaris with tretinoin and erythromycin in general practice","volume":"15","author":"Korting HC","year":"1989","journal-title":"Drugs Exp Clin Res"},{"key":"e_1_2_6_114_1","doi-asserted-by":"publisher","DOI":"10.1185\/0300799009117001"},{"key":"e_1_2_6_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.06.006"},{"key":"e_1_2_6_116_1","first-page":"94","article-title":"Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle\u2010controlled, double\u2010blind study of adapalene 0.1%\u2010benzoyl peroxide 2.5% fixed\u2010dose combination gel with doxycycline hyclate 100\u00a0mg","volume":"85","author":"Gold LS","year":"2010","journal-title":"Cutis"},{"key":"e_1_2_6_117_1","first-page":"110","article-title":"A North American study of adapalene\u2010benzoyl peroxide combination gel in the treatment of acne","volume":"84","author":"Gold LS","year":"2009","journal-title":"Cutis"},{"key":"e_1_2_6_118_1","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2014.26.1.43"},{"key":"e_1_2_6_119_1","doi-asserted-by":"publisher","DOI":"10.1159\/000350820"},{"key":"e_1_2_6_120_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10344.x"},{"key":"e_1_2_6_121_1","first-page":"64","article-title":"A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution","volume":"4","author":"Gold MH","year":"2005","journal-title":"J Drugs Dermatol"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.12989","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.12989","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.12989","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T01:33:20Z","timestamp":1717724000000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.12989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,10]]},"references-count":120,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["10.1111\/jdv.12989"],"URL":"https:\/\/doi.org\/10.1111\/jdv.12989","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,10]]}}}